Posts by: Marta Figueiredo

Marta Figueiredo

August 20, 2019August 20, 2019

Researchers Find Genetic Overlap Between Psychiatric Disorders and Psychiatric, Cognitive Symptoms in Huntington’s

News

Psychiatric and cognitive symptoms in Huntington’s disease share genetic traits with psychiatric disorders and intelligence, respectively, according to a study. These findings suggest that current treatments used for depression ... Read more

August 8, 2019August 8, 2019

HD Patients Prefer Less Invasive, No-Placebo Gene Therapy Trials, Survey Says

News

Eligible Huntington’s disease patients would likely participate in a gene therapy trial regardless of the study design, but they are more inclined toward those with less invasive interventions and ... Read more

November 29, 2018November 30, 2018

Young People Caring for Huntington’s Disease Parent Worry ‘This Could Be Me’

News

Taking care of parents with Huntington’s disease evokes thoughts of “this could be me” in young caregivers and affects their planning for predictive genetic testing, a study shows. The study, ““This ... Read more

April 3, 2018April 3, 2018

Immunotherapy Candidates Showing Promise as Potential Ways of Treating Huntington’s

News

Potential immunotherapies are showing some positive early results in clinical and preclinical tests, and may offer hope to treat Huntington’s disease, according to a recent review published in the ... Read more

March 24, 2018April 24, 2018

Cannabinoids Seen to Ease Motor Symptoms Like Dystonia in Early-onset Patients in Case Study

News

Cannabinoids can help to treat motor symptoms like dystonia in patients with early-onset Huntington’s disease, a small case study reports. The study, “Cannabinoids for Treatment of Dystonia in Huntington’s ... Read more

March 8, 2018March 8, 2018

IONIS-HTTRx Shows Promising Results in Phase 1/2 Clinical Trial

News

Ionis Pharmaceuticals‘ experimental therapy IONIS-HTTRx significantly reduced levels of the protein responsible for Huntington’s disease (HD) in early stage patients, according to top-line results from a Phase 1/2 clinical ... Read more

Pin It on Pinterest